Maze Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $21.95-$53.65 |
Market Cap | $1.8B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $20M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $20M |
Diluted EPS | -$2.48 |
News
See moreYahoo Finance • 28 days ago
Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation | DelveInsight
Yahoo Finance • last month
Could Vertex Pharmaceuticals (VRTX)’s Kidney Breakthrough Unlock a New Opportunity for Maze Therapeutics (MAZE)?
Yahoo Finance • 2 months ago
Maze Therapeutics (MAZE) Shares Moved, So What Is Driving Attention Now?
Yahoo Finance • 2 months ago
The Surprise That Sent Vertex — And Its Chief Rival — Soaring
About
CEO | Dr. Jason V. Coloma M.B.A., M.P.H., Ph.D. |
CFO | Mr. Misbah Tahir CPA |
Address | 171 Oyster Point Blvd, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 141 |